Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells

Oxaliplatin (OHP) is an anticancer agent that acts by formation of Platinum-DNA (Pt-DNA) adducts resulting in DNA-strand breaks and is used for the treatment of colorectal cancer. The pyrimidine analog trifluorothymidine (TFT) forms together with a thymidine phosphorylase inhibitor (TPI) the antican...

Descripción completa

Detalles Bibliográficos
Autores principales: Temmink, O H, Hoebe, E K, van der Born, K, Ackland, S P, Fukushima, M, Peters, G J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360012/
https://www.ncbi.nlm.nih.gov/pubmed/17242697
http://dx.doi.org/10.1038/sj.bjc.6603549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360012/
https://www.ncbi.nlm.nih.gov/pubmed/17242697
http://dx.doi.org/10.1038/sj.bjc.6603549

Ejemplares similares